NewsRamp provides syndicated and curated news distribution and marketing services for major newswires.
April 2, 2026 — NeuroOne Medical Technologies grants equity award to new employee under Nasdaq Rule 5635(c)(4), highlighting growth in neurological disorder treatments with FDA-cleared products.
April 2, 2026 — Soligenix announces HyBryte outperforms Valchlor in CTCL study with 60% treatment success and no adverse events. Read about this breakthrough in oncology therapy and its implications.
April 2, 2026 — Speranza Dental Implant Centers in Bradenton offers advanced dental implants with same-day teeth procedures, led by Drs. Kapetanakos & Caldroney. Learn more about their tech-driven, patient-focused care.
April 2, 2026 — Siouxland Oral & Maxillofacial Surgery offers expert Sioux Falls dental implants with advanced 3D imaging and patient-centered care. Learn how implants restore smiles and confidence.
April 2, 2026 — Canyon Road Dental offers comprehensive family dental care in Provo, UT, with services for all ages, modern technology, and affordable options. Visit canyonroaddentalteam.com.
April 2, 2026 — LIXTE Biotechnology files 2025 annual report highlighting clinical progress with LB-100 cancer drug, Liora acquisition, and $11M funding for oncology innovation.
April 2, 2026 — Blue Ridge Family Dental outlines 5 warning signs for root canal therapy: persistent pain, sensitivity, discoloration, gum swelling, and chewing pain. Learn why early treatment saves natural teeth.
April 2, 2026 — Lice Happens Atlanta offers chemical-free, mobile lice removal safe for pregnant women, kids, and sensitive skin. Achieves 95% success rate without pesticides or resistance risks.
April 2, 2026 — HeartBeam stock upgraded to Buy after FDA clears its portable 12-lead ECG tech. Analyst raises price target to $4, citing the company's shift to commercialization.
April 2, 2026 — Dr. Razi of Razi Orthodontics provides personalized braces and Invisalign treatment in Wheaton IL with compassionate care, flexible financing, and free consultations for confident smiles.
April 2, 2026 — Dr. Razi brings world-class braces and Invisalign to Naperville, IL, with personalized care for all ages. Learn about expert orthodontic treatments and patient-centered service at Razi Orthodontics.
April 2, 2026 — Visory Health ranks among top 3 U.S. prescription discount platforms, saving users up to 80% on medications at 37,000+ pharmacies. Learn how this health tech platform increases affordability.
April 2, 2026 — Mordor Intelligence report forecasts cancer immunotherapy market to reach $311.4B by 2031, driven by research from firms like Calidi Biotherapeutics and supportive regulations.
April 2, 2026 — Oncotelic Therapeutics partners with TechForce Robotics to commercialize AI-enabled robotics platform for pharmaceutical manufacturing, combining AI capabilities with robotics expertise for automated compliance solutions.
April 2, 2026 — American Heart Association & NFL to train thousands in free Hands-Only CPR at 2026 NFL Draft in Pittsburgh. Join Damar Hamlin to learn lifesaving skills in 90 seconds.
April 2, 2026 — Soligenix's HyBryte shows 60% treatment success vs. 20% for Valchlor in CTCL study, with no adverse events. A breakthrough in photodynamic therapy for rare cancer.
April 2, 2026 — NurExone Biologic wins BOLD Awards healthcare category for exosome therapies and partners with Investor Brand Network to boost investor outreach, advancing CNS injury treatments.
April 2, 2026 — Lantern Pharma hosts investor briefing on withZeta.ai, the first multi-agentic AI co-scientist for rare cancer drug discovery, showcasing its RADR platform and growth roadmap.
April 2, 2026 — CIRM achieves historic milestone with first FDA-approved therapy from California taxpayer funding. KRESLADI gene therapy treats rare LAD-I disease in children with 100% survival rate in trials.
April 2, 2026 — Sigyn Therapeutics launches initiative to evaluate CardioDialysis and other technologies for diagnosing and treating CTE in former NFL players, targeting chronic inflammation as a key disease driver.